Leading a Culture of Innovation
Practices
Diligence is the Hallmark of Our Services
Recent News
Read written Recent News About IP and Technology
GlobeNewswire
2025
Dragonfly Energy to be Granted U.S. Patent Strengthening Dragonfly IntelLigence® Battery Communication Technology IP
RENO, Nev., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, today announced that the United States Patent and Tra…...
Read MoreGlobeNewswire
2025
Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell carcinoma New safety and pharmacokinetic data from Phase 3 C-POST trial pro…...
Read MoreGlobeNewswire
2025
Radware AI SOC Xpert Now Covers New Use Cases To Drive Efficiencies
AI-driven incident remediation allows Security Operations Centers to better handle bot attacks, significantly improve root cause analysis and lower mean time to resolution AI-driven incident remediation allows Security Operations Centers to better handle bot …...
Read MoreBarryoreilly.com
2025
When AI Projects Are Zombies, Ghosts, or Ghouls and How to Spot Them
One evening this month, after wrapping a round of keynotes in Singapore, I found myself nursing a jet-lagged coffee in... The post When AI Projects Are Zombies, Ghosts, or Ghouls and How to Spot Them appeared first on Barry O'Reilly....
Read More
GlobeNewswire
2025
EyePoint Announces Pricing of Public Offering
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced th…...
Read MoreGlobeNewswire
2025
EyePoint Announces Proposed Public Offering of Common Stock
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced th…...
Read MoreOur Insights
Insight, Story & Blog
Get in Touch
Ready to work
together? Let's go!
MC Law loves hearing from you. Send us a message to inquire how we can solve your legal issues.
Phone: +1 202.409.1003
Email: contact@mclaw.io
Professionals
OFFICES
PROFESSIONALS
OFFICES
